News

Immagine News sito Neuranix

News

Neuranix at EUHA 2022 - 66th International EUHA Congress from October 12 to 14 2022 in Hanover, Germany

OCTOBER, 2022

We are glad to share that Neuranix was there in Hannover to present the PLAI™ (Pressure Less Acoustic Immittance) methodology for the first time in such an important Conference!

We had the opportunity to explain and present better our innovative PLAI™ patented technology for the evaluation of the status of the eardrum and the functionality of the middle ear, this generated a great interest and curiosity for its innovative concept among industy professionals.

Easy for the doctor, Easy for the patient!

The presentation about the PLAI™ generated a great interest in the audience!

For more information, please contact marketing@neuranix.com

News

Neuranix announces a new completed capital injection and a reinforced shareholder structure

AUGUST 2022

We are proud to announce that after a long period of intense R&D, product testing and the launch of our first PLAI™ based devices in the veterinary field, Neuranix has now laid the basis for the future with a new 2.1 million Euros capital increase round to back the further development of new products in the human ENT field and to support the business development efforts in the veterinary field. For more information please enjoy reading the following press release.

News

Neuranix announces a new completed capital injection and a reinforced shareholder structure

AUGUST 2022

We are proud to announce that after a long period of intense R&D, product testing and the launch of our first PLAI™ based devices in the veterinary field, Neuranix has now laid the basis for the future with a new 2.1 million Euros capital increase round to back the further development of new products in the human ENT field and to support the business development efforts in the veterinary field. For more information please enjoy reading the following press release.
neuranix_news_4

News

Neuranix receives a €120.000 grant

veneto, JUNE 2018

Within the POR – “Investment for growth and employment” objective FESR part European Regional Development Fund 2014-2020 ASSE Axis 1 ACTION 1.4.1. “Call for grants to innovative start-ups” Neuranix SRL is the beneficiary of a public contribution of € 120,000 as co-financing for the consolidation of the innovative start-up to achieve the objectives through highly specialized consultancy:

1) start the best phase of the innovative industrialisation in order to guarantee the maximum technical and commercial competitiveness of the new product;

2) the best go to market strategy thanks to a timely and complete market analysis, commercial and marketing strategies.

Structuring and analysis of commercial potential, drawing up of the business and financial plan for the definition of the best business strategy both from an economic / financial and marketing point of view.

neuranix_news_5

News

Neuranix is admitted to the Campania NewSteel incubator program (CNS) ​

Napoli, APRIL 2018

Neuranix is admitted to the Campania NewSteel incubator program (CNS) – incubator certified under the Growth Decree 2.0 – promoted by Città della Scienza and the University of Naples Federico II. CNS builds further on the twenty-year experience of Città della Scienza on the creation of businesses – Best Science Based Incubator in Europe in 2008 and support for the creation of about 150 companies – with the research infrastructure, excellent skills and great capacity to produce talent and innovation of Federico II. For Neuranix, CNS enables the company to connect with technological and business development opportunities, as well as the main national structures supporting the development of our innovative start-up.

News

Neuranix Srl

Neuranix, receives financial support from Invitalia, Ministry of Economic Development

roma, MAY 2017

Development of a diagnostic device for the clinical-audiometric investigation of middle ear pathologies.

– a subsidized loan, with no interest, in the form of the repayable grant, of a maximum amount of € 532,000.00 (of which € 106,400.00 not subject to reimbursement), equal to 70% of the eligible expenses for the realization of the investment programs presented;

– a subsidized loan, without interest, in the form of the repayable grant, of a maximum amount of € 350,000.00 (of which € 70,000.00 is not subject to reimbursement), equal to 70% of the eligible operating costs.

neuranix_news_2

ricerca e sviluppo

Privacy Policy Cookie Policy

INFORMAZIONI SOCIETARIE

Cap.Soc. 11.549,77 €
Registro imprese di Napoli NA-971341